Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Andrew Koven Insider Profile

4 Followers

Andrew Koven, Director at MetaVia, holds 21.34K shares in MetaVia (Ticker: MTVA), holds 16.97K shares in KALA BIO (Ticker: KALA), holds 1.18M shares in Aralez Pharmaceuticals (Ticker: ARLZQ).

Andrew Koven's Trading History

MTVAMetaVia		Jun 08, 2026DirectorUninformative Buy―$23.90K
KALAKALA BIO		Jun 17, 2025DirectorUninformative Buy―$2.80K
ARLZQAralez Pharmaceuticals		Jun 06, 2018―Uninformative Sell57.93K$2.37K
AUXLAuxilium		Jan 30, 2015―Uninformative Sell1.41M―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Andrew Koven insider profile FAQ

What is the percentage of profitable transactions made by Andrew Koven?
The percentage of profitable transactions made by Andrew Koven is 50%.
What is the average return per transaction made by Andrew Koven?
The average return per transaction made by Andrew Koven is 13.20%.
What stocks does Andrew Koven hold?
Andrew Koven holds: MTVA, ARLZQ, KALA, AUXL stocks.
What was Andrew Koven's most profitable transaction?
Andrew Koven’s most profitable transaction was an Informative Sell of ARLZQ stock on June 6, 2017. The return on the trade was 69.50%.
What is Andrew Koven's role in MetaVia?
Andrew Koven's role in MetaVia is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.